AFYA vs JBSS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AFYA's Piotroski F-Score of 4/9 indicates a borderline stable financial health, falling short of strong fundamentals. The absence of an Altman Z-Score raises concern about default risk, especially given a current ratio of 0.98 and quick ratio of 0.95, suggesting liquidity pressure. Despite this, the company exhibits strong profitability with a 20.08% net margin and 29.88% operating margin, and delivers robust earnings growth of 29.8% YoY. The stock trades at a significant discount to its intrinsic value of $45.43 and Graham Number of $18.59, implying undervaluation, though technicals are bearish and analyst sentiment is underperform. The dividend is sustainable with a low payout ratio of 16.73%, but the 4.82% yield may not compensate for the lack of momentum.
JBSS exhibits a stable financial profile with a Piotroski F-Score of 4/9 and a very conservative balance sheet (Debt/Equity 0.20). While the current price of $82.48 is a premium to the Graham Number ($65.33), it trades at a significant discount to its growth-based intrinsic value of $176.71. Strong operational efficiency is evident in the 20.23% ROE and consistent earnings beats, but this is offset by bearish insider sentiment and a low technical trend score. The stock represents a fundamentally sound value play currently facing internal selling pressure.
Compare Another Pair
Related Comparisons
AFYA vs JBSS: Head-to-Head Comparison
This page compares Afya Limited (AFYA) and John B. Sanfilippo & Son, Inc. (JBSS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.